Back
Biomarin Pharmaceutical Stock Price Chart
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.13
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.97 | Sell |
| 20-day SMA: | 86.7 | Sell |
| 50-day SMA: | 86.17 | Sell |
| 200-day SMA: | 87.12 | Sell |
| 8-day EMA: | 79.59 | Sell |
| 20-day EMA: | 84.09 | Sell |
| 50-day EMA: | 85.42 | Sell |
| 200-day EMA: | 86.31 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.98 | Sell |
| Relative Strength Index (14 RSI): | 20.79 | Sell |
| Chaikin Money Flow: | 1035913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (81.58 - 93.32) | Sell |
| Bollinger Bands (100): | (78.83 - 88.25) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 70.55 while BMRN 8-day simple moving average is 80.97, which is a Sell signal.
- The stock price of BMRN is 70.55 while Biomarin Pharmaceutical 20-day SMA is 86.70, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 86.17 while BMRN share price is 70.55, making it a Sell technically.
- BMRN stock price is 70.55 and Biomarin Pharmaceutical 200-day simple moving average is 87.12, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Sell
The current Biomarin Pharmaceutical [BMRN] share price is $70.55. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
13.43B
Price in USD:
70.55
Share Volume:
4.63M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
68.83
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 70.55 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 70.55 while BMRN 8-day exponential moving average is 79.59, which is a Sell signal.
- The stock price of BMRN is 70.55 while Biomarin Pharmaceutical 20-day EMA is 84.09, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 85.42 while BMRN share price is 70.55, making it a Sell technically.
- BMRN stock price is 70.55 and Biomarin Pharmaceutical 200-day simple moving average is 86.31, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -2.98, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 20.79, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (81.58 - 93.32), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (78.83 - 88.25), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.